SCHEMBL24310784

SCHEMBL24310784

Cc1ccccc1Oc1nc(NSc2cnn(C)c2)nc(Cl)c1C(F)(F)C(F)(F)F

nearest known ligand 0.32

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
▸ MAP3K7 O43318 1/20 0.32
▸ MAPK1 P28482 1/20 0.32
▸ MAP2K1 Q02750 1/20 0.32
▸ CDK1 P06493 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24309648 0.92 CDK1 (0.34) MAP3K7MAPK1MAP2K1CDK1
SCHEMBL24310085 0.87 CDK1 (0.30) CDK1
SCHEMBL24310486 0.85 JAK2 (0.32) —
SCHEMBL24310420 0.84 SCD (0.33) MAP3K7MAPK1MAP2K1
SCHEMBL24310106 0.83 DRD2 (0.34) —
SCHEMBL24310130 0.81 HTR1A (0.36) MAP3K7MAPK1MAP2K1
SCHEMBL29566383 0.81 HTR1A (0.36) MAP3K7MAPK1MAP2K1
SCHEMBL24309901 0.79 IGF1R (0.33) MAP3K7MAPK1MAP2K1
SCHEMBL24310590 0.78 IGF1R (0.31) —
SCHEMBL24309917 0.77 MAPK14 (0.33) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022076627-A1 MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR VERTEX PHARMACEUTICALS INCORPORATED (US) 2022-04-14 — — WO disclosed
Send feedback